These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 15461935)

  • 1. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
    Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
    J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size distribution of spontaneously formed liposomes by the alcohol injection method.
    Domazou AS; Luisi PL
    J Liposome Res; 2002; 12(3):205-20. PubMed ID: 12604027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice.
    Atyabi F; Farkhondehfai A; Esmaeili F; Dinarvand R
    Acta Pharm; 2009 Jun; 59(2):133-44. PubMed ID: 19564139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
    Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
    Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution.
    Flaten GE; Chang TT; Phillips WT; Brandl M; Bao A; Goins B
    J Liposome Res; 2013 Mar; 23(1):70-81. PubMed ID: 23210622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
    Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
    Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin.
    Whitaker RD; Ingebrigtsen SG; Naderkhani E; Skar ML; Flaten GE
    J Liposome Res; 2013 Dec; 23(4):298-310. PubMed ID: 23763495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts.
    Petrangolini G; Pratesi G; De Cesare M; Supino R; Pisano C; Marcellini M; Giordano V; Laccabue D; Lanzi C; Zunino F
    Mol Cancer Res; 2003 Oct; 1(12):863-70. PubMed ID: 14573787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
    J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Lipid Composition on the Liposomal Delivery of Camptothecin Developed by Active Click Loading.
    Xie L; Zhang Q; Zhu Q; Wang Y; Niu S; Zhang X; Huang Y; Li J; Liu X; Xue Z; Zhao X; Zheng Y
    Mol Pharm; 2024 May; 21(5):2327-2339. PubMed ID: 38576375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A versatile prodrug approach for liposomal core-loading of water-insoluble camptothecin anticancer drugs.
    Liu X; Lynn BC; Zhang J; Song L; Bom D; Du W; Curran DP; Burke TG
    J Am Chem Soc; 2002 Jul; 124(26):7650-1. PubMed ID: 12083906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of lipid vesicles of camptothecin as targeted drug delivery system.
    Prabhakara P; Zenia T; Marina K; Shama KP; Girish SN; Matapady NH
    Pak J Pharm Sci; 2013 Jul; 26(4):779-86. PubMed ID: 23811458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
    Koo OM; Rubinstein I; Onyuksel H
    Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.
    Ramsay E; Alnajim J; Anantha M; Zastre J; Yan H; Webb M; Waterhouse D; Bally M
    Eur J Pharm Biopharm; 2008 Mar; 68(3):607-17. PubMed ID: 17904831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects.
    Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X
    Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy.
    Xing J; Zhang X; Wang Z; Zhang H; Chen P; Zhou G; Sun C; Gu N; Ji M
    Int J Nanomedicine; 2019; 14():5201-5213. PubMed ID: 31371956
    [No Abstract]   [Full Text] [Related]  

  • 17. Liposome transport of hydrophobic drugs: gel phase lipid bilayer permeability and partitioning of the lactone form of a hydrophobic camptothecin, DB-67.
    Joguparthi V; Xiang TX; Anderson BD
    J Pharm Sci; 2008 Jan; 97(1):400-20. PubMed ID: 17879989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and comparative characterization of chitosan, gelatin, and chitosan-gelatin-coated liposomes of CPT-11-HCl.
    Shende P; Gaud R
    Drug Dev Ind Pharm; 2009 May; 35(5):612-8. PubMed ID: 18951273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors.
    Hattori Y; Shi L; Ding W; Koga K; Kawano K; Hakoshima M; Maitani Y
    J Control Release; 2009 May; 136(1):30-7. PubMed ID: 19331859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.
    Watanabe M; Kawano K; Toma K; Hattori Y; Maitani Y
    J Control Release; 2008 May; 127(3):231-8. PubMed ID: 18384903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.